Advertisement

Advertisement

Survivorship
Supportive Care
Cardio-oncology

Can Adhering to a Mediterranean Diet Reduce Mortality in Cancer Survivors?

Cancer survivors who adhere to a Mediterranean diet may survive longer and have a reduced risk of cardiovascular-related mortality compared with those who had lower adherence to the diet, according to a recent study published by Bonaccio et al in JACC: CardioOncology. Background The Mediterranean...

Solid Tumors
Cardio-oncology
Issues in Oncology

Air Pollution May Increase Cardiovascular Risk in Patients With Cancer

Air pollution may increase the risk of cardiovascular disease, mortality, and health disparities in patients with cancer, according to a recent study published by Zhu et al in JACC: CardioOncology. Background Although modern therapies may help extend the lives of patients with cancer, cancer...

Breast Cancer
Cardio-oncology
Survivorship

Cardiac Dysfunction Among Breast Cancer Survivors

In a study reported in the Journal of Clinical Oncology, Bostany et al found that the cumulative incidence of cardiac dysfunction reached 15.3% at 15 years from the start of cardiotoxic treatments in breast cancer survivors. Study Details The study involved patients at the Next Steps Breast Cancer...

Cardio-oncology

Cardiotoxicity: How Far Have We Come?

A little more than 12 months ago, the first major cardio-oncology guidelines were published by the European Society of Cardiology (ESC).1 The extensive document embodied the immense progress of this subspecialty over its short existence. In reaching this milestone, it is worth considering what...

Cardio-oncology
Survivorship

Childhood Cancer Survivors: Burden of Cardiovascular Disease and Risk of Major Cardiovascular Events

In an analysis from the St. Jude Lifetime Cohort Study (SJLIFE) reported in The Lancet Oncology, Hammoud et al found that survivors of childhood cancer had a greater risk of major adverse cardiovascular events vs matched community controls, and that an increasing burden of nonmajor events increased ...

Cardio-oncology

United Kingdom’s First Cardio-Oncology Service: 10-Year Experience

In a research letter published by Andres et al in JACC: CardioOncology, staff from Royal Brompton Hospital, Guy’s and St. Thomas’ NHS Foundation Trust in London described their experience over 10 years in the UK’s first cardio-oncology service. Study Details The study involved data from the initial ...

Cardio-oncology

Risk of Arterial Thromboembolism in Japanese Patients With Cancer

In a Japanese retrospective study reported in JACC:CardioOncology, Gon et al identified the incidence and outcomes of arterial thromboembolism in patients with cancer. Study Details The study used data on 97,448 patients with cancer (median age = 70 years) from the Osaka Cancer Registry linked with ...

Lymphoma
Geriatric Oncology
Cardio-oncology

Older Patients With Newly Diagnosed Hodgkin Lymphoma: Preexisting Heart Failure and Survival Outcomes

In a study reported in JACC: CardioOncology, Upshaw et al found that preexisting heart failure was associated with an increased risk of lymphoma and cardiovascular mortality among patients aged ≥ 65 years who were newly diagnosed with Hodgkin lymphoma. The study used linked Surveillance,...

Cardio-oncology

Combined ICI and VEGF Inhibitor Trials in Cancer: Cardiovascular Eligibility Criteria and Adverse Event Reporting

In a study reported in JACC:CardioOncology, Rankin et al analyzed the degree to which published phase II to IV trials of combination immune checkpoint inhibitor (ICI) and VEGF inhibitor treatment for cancer reported cardiovascular eligibility criteria and adverse events. As stated by the...

Breast Cancer
Survivorship
Cardio-oncology

Observing a Healthy Diet May Reduce Risk of Cardiovascular Disease in Breast Cancer Survivors

Following a healthy diet may reduce the risk of cardiovascular disease in female breast cancer survivors, according to a recent study published by Ergas et al in JNCI Cancer Spectrum. Background Cardiovascular disease is one of the leading causes of non–breast cancer–related mortality among...

Cardio-oncology

Promoting Cardiovascular Health in Adult Survivors of Childhood Cancers

Although more than 85% of childhood cancer survivors will achieve a 5-year survival,1 that does not tell the whole tale for these individuals who move into adulthood. They are at excess risk of late mortality, even 40 years out from a cancer diagnosis, from non–cancer-related causes,1 and related...

Cardio-oncology
Leukemia

Strategies for Cardiovascular Risk Mitigation and Monitoring in Patients With CLL

With a 5-year overall survival of close to 90% in chronic lymphocytic leukemia (CLL), there have been large treatment shifts over the past decade in this disease, which now includes “more disciplines than it did before,” commented medical oncologist Danielle Shafer, DO, of Inova Schar Cancer...

Cardio-oncology
Lung Cancer

Risks of Cardiovascular Disease in Patients Receiving Therapies for Lung Cancer

Managing patients with lung cancer in the current era of an increasing array of systemic treatments has become a complex balancing act of trying to improve outcomes and survival from a cancer perspective while taking the necessary treatment and monitoring steps for cardioprotection. With few...

Hematologic Malignancies
Cardio-oncology

Risk Score to Assess Cardiovascular Complications in Hematopoietic Stem Cell Transplant Recipients

A novel tool may help predict the risk of complications following hematopoietic stem cell transplantation and guide the pretransplant process, according to new Scientific Statement published by Hayek et al in Circulation. The findings may also illuminate the contemporary prevalence of...

Cardio-oncology

Relationship Between Second Malignant Neoplasm and Heart Disease Studied in Childhood Cancer Survivors

In a French study of more than 7,000 childhood cancer survivors, published in JACC: CardioOncology, Thibaud Charrier, PhD, of the Université Paris-Saclay, Villejuif, France, and colleagues reported that the occurrence of a second malignant neoplasm among these childhood cancer survivors seemed to...

Cardio-oncology

Sleep Apnea May Be Prevalent Among Patients With Cancer at High Risk of Congestive Heart Failure

Sleep apnea may be prevalent among patients who are at higher risk of developing congestive heart failure from cancer therapy, according to new findings presented by Das et al at the American College of Cardiology (ACC) Advancing the Cardiovascular Care of the Oncology Patient course. Background...

Solid Tumors
Survivorship
Cardio-oncology

Novel Biomarker in Cancer Survivors May Be Linked to Higher Risk of Mortality

Elevated N-terminal pro–brain natriuretic peptide (NT-proBNP) levels may be associated with a higher risk of mortality among cancer survivors, according to a recent study published by Cao et al in the Journal of the National Cancer Institute. NT-proBNP—produced in response to the stretching of...

Cardio-oncology

Cardio-Oncology Is a Growing Subspecialty, but Where Are the Oncologists?

It has been almost 20 years since the approval of trastuzumab for the treatment of early-stage, HER2-positive breast cancer. I remember returning from the 2005 ASCO Annual Meeting excited to offer patients a treatment that led to significant improvement in clinical outcomes. However, within a short ...

Survivorship
Cardio-oncology

Survivors of Childhood Cancer With High Anthracycline Exposure: Can a Beta-Blocker Improve Cardiac Function?

In a U.S./Canadian phase IIb trial (PREVENT-HF) reported in The Lancet Oncology, Armenian et al found that the beta-blocker carvedilol did not significantly improve cardiac function—measured as standardized left ventricular wall thickness–dimension ratio Z score (LVWT/Dz)—vs placebo in survivors of ...

Sarcoma
Immunotherapy
Cardio-oncology

Immunotherapy Outcomes in Patients With Primary Cardiac Soft-Tissue Sarcomas

In a U.S. multicenter retrospective analysis reported in JACC: CardioOncology, Amin H. Nassar, MD, and colleagues found that immune checkpoint inhibition resulted in mostly moderate activity in patients with primary cardiac soft-tissue sarcomas. Study Details The study included 24 patients with...

Cardio-oncology

International Collaborative Research Efforts in Cardio-Oncology

At the 2023 Global Cardio-Oncology Symposium (GCOS), international experts explored the ongoing collaborative efforts to improve the cardiovascular health of patients being treated for cancer as well as the bidirectional challenges of translating basic research to clinical care. Focus on Basic and...

Cardio-oncology

Use of Direct Oral Anticoagulant Agents in Active Cancer: Meta-Analysis

In a systematic review and meta-analysis reported in JACC: CardioOncology, Fujisaki et al found no significant differences among direct oral anticoagulant agents (DOACs) in the prevention of recurrent venous thromboembolism (VTE) associated with active cancer, whereas significant differences in...

Survivorship
Cardio-oncology

Use of Carvedilol to Help Prevent Heart Failure in Childhood Cancer Survivors

Researchers discovered that the blood vessel–relaxing agent carvedilol may be safe and effective at reducing the risk of heart failure in childhood cancer survivors, according to a recent study published by Armenian et al in The Lancet Oncology. These findings indicate carvedilol may improve...

Cardio-oncology

Immune Checkpoint Inhibitor–Induced Myocarditis: Contemporary Retrospective Analysis

In a retrospective cohort study of 160 patients with cancer who were suspected of having immune checkpoint inhibitor (ICI)-induced myocarditis, published in JACC: CardioOncology, Osnat Itzhaki Ben Zadok, MD, MSc, and colleagues found that severe ICI-induced myocarditis seemed to be linked to...

Cardio-oncology

International Collaborative Research Efforts in Cardio-oncology: Focus on Basic and Translational Science

Translational research is a key ingredient in guiding both genetic and pharmacologic cardioprotective approaches in patients being treated for cancer, according to international experts from the International Cardio-Oncology Society and the Global Cardio-Oncology Symposium (GCOS) committee. Fadi N. ...

Survivorship
Cardio-oncology

Is Prediabetes Linked to Cardiovascular and Kidney Diseases in Adult Survivors of Childhood Cancer?

In a study reported in the Journal of Clinical Oncology, Dixon et al found that adult survivors of childhood cancers with prediabetes were at an increased risk of developing cardiovascular events and chronic kidney disease. The study involved data from 3,529 ≥ 5-year survivors of childhood cancer...

Cardio-oncology

Childhood Cancer Survivors: Risk of Second Cancer and Heart Disease

In a French study of more than 7,000 childhood cancer survivors published by Charrier et al in JACC: CardioOncology, researchers reported that the occurrence of a second malignant neoplasm among these survivors seemed to be associated with an increased risk of cardiac disease occurrence and risk at ...

Cardio-oncology

Cardiac Imaging and Biomarkers for Patients Receiving Cancer Treatment: What Oncologists Need to Know

For many years, researchers around the world have been exploring the connections between cancer treatments and the heart—better known as cardio-oncology. However, many oncologists may be less familiar with this emerging field and what they might need to know in terms of heart health to keep their...

Cardio-oncology

Cardiovascular Disease and Cancer: A Reciprocal Relationship?

More attention is being paid to the topic of cardio-oncology, where the focus is on patients with cancer who may be at risk for developing cardiovascular diseases as a result of anticancer treatments. However, a less well-known but related clinical area is now garnering some interest. Referred to...

Cardio-oncology

Diagnosis of Cardiovascular Disease and Risk of Subsequent Incident Cancer Diagnosis

In a retrospective cohort study reported in JACC: CardioOncology, Caitlin F. Bell, MD, of the Division of Cardiovascular Medicine, Stanford University School of Medicine, and colleagues found that persons with a diagnosis of cardiovascular disease (CVD) were more likely to have a subsequent...

Cardio-oncology
Survivorship

Risk Factors for Incident Heart Failure Among Cancer Survivors Aged 18 to 39

In a study reported in a research letter in JACC: CardioOncology, Hibler et al found that survivors of young adult cancers who were exposed to anthracyclines were at an increased risk of subsequent diagnosis of heart failure. Study Details The study involved electronic health record data from the...

Cardio-oncology

Is Cardiovascular Disease Linked to Increased Risk of Cancer?

In a retrospective cohort study reported in JACC: CardioOncology, Bell et al found individuals with a diagnosis of cardiovascular disease were more likely to have a subsequent cancer diagnosis than individuals with no cardiovascular disease diagnosis. Risk was elevated among persons with...

Solid Tumors
Issues in Oncology
Cardio-oncology

Edoxaban Taken for 12 Months May Improve Outcomes in Patients With Cancer and Isolated Distal Deep Vein Thrombosis

Researchers have found that 12 months of the oral factor Xa inhibitor edoxaban may be superior to 3 months for the reduction of thrombotic events in patients with cancer and distal deep vein thrombosis, according to new findings presented by Yamashita et al at the European Society of Cardiology...

Lymphoma
Cardio-oncology

Effect of Atorvastatin on Cardiac Dysfunction in Patients Receiving Anthracyclines for Lymphoma

In a study (STOP-CA) reported in JAMA, Neilan et al found that atorvastatin reduced the risk of decreased left ventricular ejection fraction (LVEF) in patients receiving anthracycline-based chemotherapy for the treatment of lymphoma. Study Details In the U.S.-Canadian double-blind trial, 300...

Survivorship
Cardio-oncology

How Multidisciplinary Specialties Are Coming Together to Improve the Quality of Life of Cancer Survivors

As we detailed in our Special Report “Surviving, but Not Always Thriving, After Cancer,” in the May 25, 2023, issue of The ASCO Post, the combination of advances in more effective therapies to treat cancer, gains in early detection, and sharp declines in tobacco use have led to a staggering 33%...

Issues in Oncology
Lymphoma
Leukemia
Cardio-oncology

Findings on Cardiovascular Imaging in Patients Receiving Ibrutinib: Association With Cardiotoxicity

In a study reported in JAMA Oncology, Buck et al found that myocardial injury detected on cardiovascular magnetic resonance imaging (CMR) was common in patients treated with ibrutinib and was associated with an increased risk of major adverse cardiac events. Study Details The study included data...

Immunotherapy
Cardio-oncology

Hormone Therapy May Lower Risk of Immune Checkpoint Inhibitor–Associated Myocarditis in Female Patients

Researchers may have discovered the underlying cause of sex differences in immune checkpoint inhibitor–associated myocarditis after immune checkpoint inhibitor treatment, according to a novel study published by Zhang et al in Science Translational Medicine. Their findings pointed to possible...

Issues in Oncology
Cardio-oncology

Association of Social Vulnerability With Mortality From Comorbid Cancer and Cardiovascular Disease

In a U.S. cross-sectional study reported in JACC:CardioOncology, Ganatra et al found that mortality from comorbid cancer and cardiovascular disease was significantly higher in counties with higher vs lower social vulnerability (ie, age greater than vs less than 45, male vs female sex, Black vs...

Survivorship
Solid Tumors
Cardio-oncology

Cardiovascular Mortality and Cancer Mortality Over Time Among Cancer Survivors

In an English retrospective cohort study reported in JACC: Cardio-Oncology, Helen Strongman, PhD, of the Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, and colleagues found that cardiovascular mortality ultimately exceeded mortality from common...

Geriatric Oncology
Cardio-oncology

Geriatrics Experts Explore Relationship Between Heart Disease and Cancer

Experts’ discussions and recommendations addressing the interface between cancer and heart disease were published by Supriya Mohile, MD, MS, and colleagues in the Journal of the American Geriatrics Society, summarizing sessions from a virtual bench-to-bedside conference hosted by the American...

Global Cancer Care
Cardio-oncology

Cancer and War in Ukraine: How the World Can Help Win This Battle

In Ukraine, with a population of about 44 million, there are more than 1.3 million patients with cancer. Approximately 160,000 new cases of cancer are diagnosed each year.1 In almost every region, there are local cancer centers; specialized oncologic centers are located in large cities. In Kyiv,...

Breast Cancer
Cardio-oncology

Association of Lifestyle and Cardiovascular Risk Factors With Hospitalization for Heart Failure Subtypes in Breast Cancer Survivors

In an analysis from the Women’s Health Initiative reported in JACC: CardioOncology, Kerryn W. Reding, PhD, MPH, RN, of the University of Washington at Seattle, and colleagues, identified the incidence of hospitalization for heart failure among postmenopausal breast cancer survivors. They reported...

Breast Cancer
Survivorship
Cardio-oncology

How Do Lifestyle and Cardiovascular Risk Factors Relate to Heart Failure Subtypes in Postmenopausal Breast Cancer Survivors?

In an analysis from the Women’s Health Initiative reported in JACC: CardioOncology, Kerryn W. Reding, PhD, MPH, RN, and colleagues identified the incidence of hospitalization for heart failure among postmenopausal breast cancer survivors, finding that both incidence of hospitalization and risk of...

Leukemia
Cardio-oncology

After Two Cancer Diagnoses, I’m Grateful for Another Day

The start of January 2014 was filled with excitement. I was undergoing fertility treatments to have a second child and was living my professional dream. I was a network news anchor and medical news reporter for a national broadcast network. Although I was exhausted from my grueling early morning...

Cardio-oncology

Kerryn Reding, PhD, MPH, RN, Daughter of Health-Care Workers, Chooses a Career in Breast Cancer Survivorship

Kerryn Reding, PhD, MPH, RN—whose research focuses on reducing cancer incidence and improving survival, with particular interests in lifestyle interventions and biomarkers of risk—was born in Australia, but her family moved to Iowa when she was a toddler. “Both of my parents were in health care. My ...

Issues in Oncology
Cardio-oncology

Newer Cancer Therapies Offer Hope but Also May Confer Cardiac Risk

Since many different chemotherapeutic agents have been linked with cardiac adverse events, there is a growing need for strategies for the assessment and mitigation of treatment-induced cardiotoxicity. Moreover, the rapid rise of immunotherapies has added a new dimension to this clinical setting....

Cardio-oncology

Cardio-oncology

The ASCO Post is pleased to reproduce installments of the Art of Oncology as published previously in the Journal of Clinical Oncology. These articles focus on the experience of suffering from cancer or of caring for people diagnosed with cancer, and they include narratives, topical essays,...

Issues in Oncology
Cost of Care
Cardio-oncology

Financial Impact of Cardiovascular Disease and Cancer Care: Overlapping Toxicities

The leading causes of mortality in the United States are cardiovascular disease (23%) and cancer (21%), accounting for more than 40% of total deaths reported.1,2 The increasing rise in health-care expenditures over the past several decades has driven the need for metrics to further evaluate the...

Cardio-oncology

A Career in Cardio-oncology Founded on Simple Principles Taught by Her Immigrant Parents

Cardio-oncology focuses on the detection, monitoring, and treatment of cardiovascular disease occurring secondary to cancer treatment, and the mechanistic and epidemiologic intersection between cardiovascular disease and cancer. With the advent of targeted agents and immunotherapies,...

Solid Tumors
Cardio-oncology

Shared Risk Factors for Preventing Cancer and Cardiovascular Disease: The Evolving Focus of Cardio-oncology

Cardio-oncology represents the intersection of cancer and cardiovascular disease. Cancer therapies can result in cardiovascular complications, and some patients become less attentive to their chronic disease management after a diagnosis of cancer. As cancer patients are living longer, for some,...

Advertisement

Advertisement

Advertisement